Announcements Trials
Browse Landscape

Phase

Phase 2 107Phase 3 42Phase 1 26Phase 1/2 18Phase 2/3 4Phase NA 3Phase 4 3

Status

Completed 2Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Thoracic 4

Conditions

Breast Neoplasms 12Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 6Fallopian Tube Neoplasms 5Lung Neoplasms 4Stomach Neoplasms 3Esophageal Squamous Cell Carcinoma 3Esophageal Neoplasms 3Endometrial Neoplasms 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Inflammatory Breast Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Ductal, Breast 2Adenocarcinoma Of Esophagus 2Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1The Neoadjuvant Therapy 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Teratoma 1Stage IIIB or IV Non-Small Cell Lung Cancer 1Seminoma 1Recurrence 1Primary Malignant Neoplasm of Ovary 1Peripheral Nervous System Diseases 1Pancreatic Neoplasms 1Neoplasms, Cystic, Mucinous, and Serous 1Neoplasm Metastasis 1

Interventions

Cisplatin 6Pemetrexed 5Carboplatin 5pembrolizumab 4Paclitaxel 4Magnetic Resonance Spectroscopy 4Docetaxel 4Gemcitabine 3Dexamethasone 3dexamethasone acetate 2dexamethasone 21-phosphate 2cemiplimab 2auricularum 2Specimen Handling 2Ramucirumab 2Radiotherapy 2Leucovorin 2Erlotinib Hydrochloride 2Drug Therapy 2Calcium Dobesilate 2pertuzumab 1oblimersen 1maimendongtang 1endostar protein 1cyclopropapyrroloindole 1cediranib 1aumolertinib 1anamorelin 1Vitamin B 12 1Vinorelbine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2/3 × Lung Neoplasms × Paclitaxel × Clear all
NCT07063745 2026-05-18

MountainTAP-29

Bristol-Myers Squibb

Phase 2/3 Recruiting
590 enrolled
Thoracic

Lung Neoplasms

NCT05800015 2026-01-22

A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

Regeneron Pharmaceuticals

Phase 2/3 Active not recruiting
950 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00245154 2023-08-04

Paclitaxel + Carboplatin With/Out Cediranib Maleate in Stage III or Stage IV Non-Small Cell Lung Cancer

Canadian Cancer Trials Group

Phase 2/3 Completed
296 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00006229 2020-04-06

Paclitaxel + Carboplatin With/ut BMS-275291 in Advanced or Metastatic Non-small Cell Lung Cancer

Canadian Cancer Trials Group

Phase 2/3 Completed
774 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡